First Time Loading...
C

Changzhou Qianhong Biopharma Co Ltd
SZSE:002550

Watchlist Manager
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Watchlist
Price: 5.8 CNY 0.69% Market Closed
Updated: May 18, 2024

Changzhou Qianhong Biopharma Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Changzhou Qianhong Biopharma Co Ltd
Operating Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Operating Income
¥193.7m
CAGR 3-Years
N/A
CAGR 5-Years
8%
CAGR 10-Years
3%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥2.6B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.5B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥4.8B
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
12%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.9B
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
4%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Operating Income
-¥749.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Changzhou Qianhong Biopharma Co Ltd's Operating Income?
Operating Income
193.7m CNY

Based on the financial report for Mar 31, 2024, Changzhou Qianhong Biopharma Co Ltd's Operating Income amounts to 193.7m CNY.

What is Changzhou Qianhong Biopharma Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
3%

Over the last year, the Operating Income growth was -36%.